Does the media refer more to COIN or SI?

In the previous week, Coinbase Global had 60 more articles in the media than Shoulder Innovations. MarketBeat recorded 62 mentions for Coinbase Global and 2 mentions for Shoulder Innovations. Shoulder Innovations' average media sentiment score of 0.67 beat Coinbase Global's score of 0.59 indicating that Shoulder Innovations is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Coinbase Global 23 Very Positive mention(s) 15 Positive mention(s) 20 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Shoulder Innovations 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor CNMD or SI?

In the previous week, CONMED and CONMED both had 2 articles in the media. Shoulder Innovations' average media sentiment score of 0.67 beat CONMED's score of 0.23 indicating that Shoulder Innovations is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CONMED 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Shoulder Innovations 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor SI or IART?

In the previous week, Integra LifeSciences had 13 more articles in the media than Shoulder Innovations. MarketBeat recorded 15 mentions for Integra LifeSciences and 2 mentions for Shoulder Innovations. Shoulder Innovations' average media sentiment score of 0.67 beat Integra LifeSciences' score of 0.31 indicating that Shoulder Innovations is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Shoulder Innovations 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Integra LifeSciences 1 Very Positive mention(s) 2 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer SI or BVS?

In the previous week, Bioventus had 1 more articles in the media than Shoulder Innovations. MarketBeat recorded 3 mentions for Bioventus and 2 mentions for Shoulder Innovations. Shoulder Innovations' average media sentiment score of 0.67 beat Bioventus' score of 0.34 indicating that Shoulder Innovations is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Shoulder Innovations 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Bioventus 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Shoulder Innovations (SI) Competitors

$19.03 +0.28 (+1.49%)

Closing price 03:59 PM Eastern

Extended Trading

$19.04 +0.00 (+0.03%)

As of 07:30 PM Eastern

Compare

SI vs. COIN, CNMD, DRTS, IART, and BVS

Should you buy Shoulder Innovations stock or one of its competitors? Shoulder Innovations's main competitors and comparable companies include Coinbase Global (COIN), CONMED (CNMD), Alpha Tau Medical (DRTS), Integra LifeSciences (IART), and Bioventus (BVS). Companies are selected based on similarities in market, industry, and size.

How does Shoulder Innovations compare to Coinbase Global?

Coinbase Global (NASDAQ:COIN) and Shoulder Innovations (NYSE:SI) are related companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, dividends, media sentiment, institutional ownership, analyst recommendations and profitability.

Coinbase Global has higher revenue and earnings than Shoulder Innovations. Coinbase Global is trading at a lower price-to-earnings ratio than Shoulder Innovations, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Coinbase Global	$7.18B	6.73	$1.26B	-$3.84	N/A
Shoulder Innovations	$47.32M	8.31	-$40.36M	-$1.92	N/A

Coinbase Global presently has a consensus price target of $222.98, suggesting a potential upside of 21.67%. Shoulder Innovations has a consensus price target of $25.50, suggesting a potential upside of 35.09%. Given Shoulder Innovations' stronger consensus rating and higher possible upside, analysts plainly believe Shoulder Innovations is more favorable than Coinbase Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Coinbase Global	3 Sell rating(s)	13 Hold rating(s)	20 Buy rating(s)	0 Strong Buy rating(s)	2.47
Shoulder Innovations	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.67

68.8% of Coinbase Global shares are held by institutional investors. 16.7% of Coinbase Global shares are held by insiders. Comparatively, 29.0% of Shoulder Innovations shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Coinbase Global had 60 more articles in the media than Shoulder Innovations. MarketBeat recorded 62 mentions for Coinbase Global and 2 mentions for Shoulder Innovations. Shoulder Innovations' average media sentiment score of 0.67 beat Coinbase Global's score of 0.59 indicating that Shoulder Innovations is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Coinbase Global	23 Very Positive mention(s)	15 Positive mention(s)	20 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
Shoulder Innovations	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Coinbase Global has a net margin of -15.72% compared to Shoulder Innovations' net margin of -58.33%. Coinbase Global's return on equity of 3.12% beat Shoulder Innovations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Coinbase Global	-15.72%	3.12%	1.54%
Shoulder Innovations	-58.33%	-23.61%	-19.53%

Coinbase Global has a beta of 3.41, meaning that its stock price is 241% more volatile than the broader market. Comparatively, Shoulder Innovations has a beta of -1.57, meaning that its stock price is 257% less volatile than the broader market.

Summary

Coinbase Global beats Shoulder Innovations on 9 of the 16 factors compared between the two stocks.

How does Shoulder Innovations compare to CONMED?

CONMED (NYSE:CNMD) and Shoulder Innovations (NYSE:SI) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, risk, analyst recommendations, institutional ownership, valuation and earnings.

CONMED has a net margin of 4.12% compared to Shoulder Innovations' net margin of -58.33%. CONMED's return on equity of 14.31% beat Shoulder Innovations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CONMED	4.12%	14.31%	6.33%
Shoulder Innovations	-58.33%	-23.61%	-19.53%

CONMED has a beta of 0.94, suggesting that its share price is 6% less volatile than the broader market. Comparatively, Shoulder Innovations has a beta of -1.57, suggesting that its share price is 257% less volatile than the broader market.

CONMED currently has a consensus target price of $41.40, suggesting a potential downside of 11.01%. Shoulder Innovations has a consensus target price of $25.50, suggesting a potential upside of 35.09%. Given Shoulder Innovations' stronger consensus rating and higher possible upside, analysts plainly believe Shoulder Innovations is more favorable than CONMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CONMED	1 Sell rating(s)	7 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.88
Shoulder Innovations	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.67

CONMED has higher revenue and earnings than Shoulder Innovations. Shoulder Innovations is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CONMED	$1.37B	1.01	$47.06M	$1.85	25.15
Shoulder Innovations	$47.32M	8.31	-$40.36M	-$1.92	N/A

In the previous week, CONMED and CONMED both had 2 articles in the media. Shoulder Innovations' average media sentiment score of 0.67 beat CONMED's score of 0.23 indicating that Shoulder Innovations is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CONMED	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Shoulder Innovations	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

CONMED beats Shoulder Innovations on 8 of the 13 factors compared between the two stocks.

How does Shoulder Innovations compare to Alpha Tau Medical?

Shoulder Innovations (NYSE:SI) and Alpha Tau Medical (NASDAQ:DRTS) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, media sentiment, earnings, profitability and dividends.

2.7% of Alpha Tau Medical shares are held by institutional investors. 29.0% of Shoulder Innovations shares are held by insiders. Comparatively, 39.5% of Alpha Tau Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Shoulder Innovations has a beta of -1.57, suggesting that its stock price is 257% less volatile than the broader market. Comparatively, Alpha Tau Medical has a beta of 1.22, suggesting that its stock price is 22% more volatile than the broader market.

In the previous week, Shoulder Innovations had 2 more articles in the media than Alpha Tau Medical. MarketBeat recorded 2 mentions for Shoulder Innovations and 0 mentions for Alpha Tau Medical. Shoulder Innovations' average media sentiment score of 0.67 beat Alpha Tau Medical's score of 0.00 indicating that Shoulder Innovations is being referred to more favorably in the media.

Company	Overall Sentiment
Shoulder Innovations	Positive
Alpha Tau Medical	Neutral

Shoulder Innovations currently has a consensus price target of $25.50, suggesting a potential upside of 35.09%. Alpha Tau Medical has a consensus price target of $15.40, suggesting a potential upside of 4.62%. Given Shoulder Innovations' stronger consensus rating and higher possible upside, analysts clearly believe Shoulder Innovations is more favorable than Alpha Tau Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shoulder Innovations	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.67
Alpha Tau Medical	2 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.38

Shoulder Innovations has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Shoulder Innovations, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shoulder Innovations	$47.32M	8.31	-$40.36M	-$1.92	N/A
Alpha Tau Medical	N/A	N/A	-$42.63M	-$1.04	N/A

Alpha Tau Medical has a net margin of 0.00% compared to Shoulder Innovations' net margin of -58.33%. Shoulder Innovations' return on equity of -23.61% beat Alpha Tau Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shoulder Innovations	-58.33%	-23.61%	-19.53%
Alpha Tau Medical	N/A	-138.12%	-81.68%

Summary

Shoulder Innovations beats Alpha Tau Medical on 9 of the 14 factors compared between the two stocks.

How does Shoulder Innovations compare to Integra LifeSciences?

Shoulder Innovations (NYSE:SI) and Integra LifeSciences (NASDAQ:IART) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, institutional ownership, media sentiment, profitability and earnings.

Shoulder Innovations has a beta of -1.57, suggesting that its share price is 257% less volatile than the broader market. Comparatively, Integra LifeSciences has a beta of 1.21, suggesting that its share price is 21% more volatile than the broader market.

84.8% of Integra LifeSciences shares are held by institutional investors. 29.0% of Shoulder Innovations shares are held by insiders. Comparatively, 3.8% of Integra LifeSciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Shoulder Innovations has higher earnings, but lower revenue than Integra LifeSciences. Integra LifeSciences is trading at a lower price-to-earnings ratio than Shoulder Innovations, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shoulder Innovations	$47.32M	8.31	-$40.36M	-$1.92	N/A
Integra LifeSciences	$1.64B	0.61	-$516.47M	-$0.09	N/A

Shoulder Innovations currently has a consensus price target of $25.50, indicating a potential upside of 35.09%. Integra LifeSciences has a consensus price target of $18.86, indicating a potential upside of 46.53%. Given Integra LifeSciences' higher probable upside, analysts plainly believe Integra LifeSciences is more favorable than Shoulder Innovations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shoulder Innovations	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.67
Integra LifeSciences	2 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.88

In the previous week, Integra LifeSciences had 13 more articles in the media than Shoulder Innovations. MarketBeat recorded 15 mentions for Integra LifeSciences and 2 mentions for Shoulder Innovations. Shoulder Innovations' average media sentiment score of 0.67 beat Integra LifeSciences' score of 0.31 indicating that Shoulder Innovations is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Shoulder Innovations	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Integra LifeSciences	1 Very Positive mention(s)	2 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Integra LifeSciences has a net margin of -0.44% compared to Shoulder Innovations' net margin of -58.33%. Integra LifeSciences' return on equity of 18.30% beat Shoulder Innovations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shoulder Innovations	-58.33%	-23.61%	-19.53%
Integra LifeSciences	-0.44%	18.30%	5.30%

Summary

Integra LifeSciences beats Shoulder Innovations on 9 of the 16 factors compared between the two stocks.

How does Shoulder Innovations compare to Bioventus?

Shoulder Innovations (NYSE:SI) and Bioventus (NASDAQ:BVS) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, analyst recommendations, risk, institutional ownership and media sentiment.

In the previous week, Bioventus had 1 more articles in the media than Shoulder Innovations. MarketBeat recorded 3 mentions for Bioventus and 2 mentions for Shoulder Innovations. Shoulder Innovations' average media sentiment score of 0.67 beat Bioventus' score of 0.34 indicating that Shoulder Innovations is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Shoulder Innovations	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Bioventus	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Shoulder Innovations has a beta of -1.57, meaning that its stock price is 257% less volatile than the broader market. Comparatively, Bioventus has a beta of 0.65, meaning that its stock price is 35% less volatile than the broader market.

62.9% of Bioventus shares are held by institutional investors. 29.0% of Shoulder Innovations shares are held by company insiders. Comparatively, 33.5% of Bioventus shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Shoulder Innovations currently has a consensus target price of $25.50, suggesting a potential upside of 35.09%. Bioventus has a consensus target price of $16.80, suggesting a potential upside of 27.22%. Given Shoulder Innovations' higher possible upside, equities analysts plainly believe Shoulder Innovations is more favorable than Bioventus.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shoulder Innovations	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.67
Bioventus	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.83

Bioventus has higher revenue and earnings than Shoulder Innovations. Shoulder Innovations is trading at a lower price-to-earnings ratio than Bioventus, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shoulder Innovations	$47.32M	8.31	-$40.36M	-$1.92	N/A
Bioventus	$581.85M	1.91	$22.73M	$0.77	17.15

Bioventus has a net margin of 9.36% compared to Shoulder Innovations' net margin of -58.33%. Bioventus' return on equity of 28.08% beat Shoulder Innovations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shoulder Innovations	-58.33%	-23.61%	-19.53%
Bioventus	9.36%	28.08%	9.82%

Summary

Bioventus beats Shoulder Innovations on 12 of the 15 factors compared between the two stocks.

Get Shoulder Innovations News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SI vs. The Competition

Export

Metric	Shoulder Innovations	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$390.36M	$5.48B	$7.14B	$22.65B
Dividend Yield	N/A	1.81%	2.54%	3.73%
P/E Ratio	-9.91	20.68	214.49	24.00
Price / Sales	8.37	67.77	607.75	21.41
Price / Cash	N/A	32.43	77.60	38.88
Price / Book	2.79	5.68	10.92	4.64
Net Income	-$40.36M	$152.11M	$3.50B	$1.08B
7 Day Performance	11.55%	-2.01%	-2.11%	-1.06%
1 Month Performance	-7.71%	-5.42%	-6.34%	-5.03%
1 Year Performance	57.79%	2.75%	8.81%	5.78%

Shoulder Innovations Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SI Shoulder Innovations	2.6035 of 5 stars	$19.03 +1.5%	$25.50 +34.0%	+55.3%	$390.36M	$47.32M	N/A	75
COIN Coinbase Global	3.9342 of 5 stars	$195.11 -2.1%	$219.97 +12.7%	-45.3%	$52.56B	$7.18B	N/A	4,951	Trending News Analyst Forecast Gap Up
CNMD CONMED	1.8636 of 5 stars	$45.41 +0.5%	$41.40 -8.8%	-2.8%	$1.35B	$1.37B	24.54	3,900	News Coverage
DRTS Alpha Tau Medical	1.1499 of 5 stars	$14.54 -1.6%	$15.40 +5.9%	+232.0%	$1.33B	N/A	N/A	121
IART Integra LifeSciences	3.8574 of 5 stars	$16.12 +1.5%	$18.86 +17.0%	+9.2%	$1.24B	$1.64B	N/A	4,427	Trending News Analyst Upgrade Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:SI) was last updated on 10/2/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Shoulder Innovations (SI) Competitors

SI vs. COIN, CNMD, DRTS, IART, and BVS

How does Shoulder Innovations compare to Coinbase Global?

Summary

How does Shoulder Innovations compare to CONMED?

Summary

How does Shoulder Innovations compare to Alpha Tau Medical?

Summary

How does Shoulder Innovations compare to Integra LifeSciences?

Summary

How does Shoulder Innovations compare to Bioventus?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SI vs. The Competition

Shoulder Innovations Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Shoulder Innovations (SI) Competitors

SI vs. COIN, CNMD, DRTS, IART, and BVS

How does Shoulder Innovations compare to Coinbase Global?

Which has stronger valuation & earnings, COIN or SI?

Do analysts recommend COIN or SI?

Do institutionals & insiders hold more shares of COIN or SI?

Does the media refer more to COIN or SI?

Is COIN or SI more profitable?

Which has more risk and volatility, COIN or SI?

Summary

How does Shoulder Innovations compare to CONMED?

Is CNMD or SI more profitable?

Which has more volatility and risk, CNMD or SI?

Do analysts rate CNMD or SI?

Which has stronger valuation and earnings, CNMD or SI?

Does the media favor CNMD or SI?

Summary

How does Shoulder Innovations compare to Alpha Tau Medical?

Do insiders and institutionals hold more shares of SI or DRTS?

Which has more risk and volatility, SI or DRTS?

Does the media prefer SI or DRTS?

Do analysts recommend SI or DRTS?

Which has preferable valuation and earnings, SI or DRTS?

Is SI or DRTS more profitable?

Summary

How does Shoulder Innovations compare to Integra LifeSciences?

Which has more risk & volatility, SI or IART?

Do institutionals and insiders hold more shares of SI or IART?

Which has higher valuation & earnings, SI or IART?

Do analysts recommend SI or IART?

Does the media favor SI or IART?

Is SI or IART more profitable?

Summary

How does Shoulder Innovations compare to Bioventus?

Does the media prefer SI or BVS?

Which has more risk & volatility, SI or BVS?

Do institutionals & insiders hold more shares of SI or BVS?

Do analysts rate SI or BVS?

Which has higher earnings & valuation, SI or BVS?

Is SI or BVS more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SI vs. The Competition

Shoulder Innovations Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools